Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

Pathophysiology of Diabetes

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...

Targets for Drug Action: Overview

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Prolonged mpox infection and fatal outcome in an HIV patient treated with tecovirimat.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026

Same author

The evolving field of nephrology: what comes next? A report from the European Renal Association Scientific Advisory Board.

Clinical kidney journal·2026

Same author

Natural Language Processing of Unstructured Healthcare Data for Predicting Heart Failure in Individuals with Type 2 Diabetes.

Journal of clinical medicine·2026

Same author

Systemic inflammatory profiles are associated with long-term kidney failure and patient mortality in chronic kidney disease.

Clinical kidney journal·2026

Same author

Endogenous α-Klotho is a common target in atherosclerosis and calcific aortic valve disease.

Biochemical pharmacology·2026

Same author

Masked alterations of glucose metabolism among patients awaiting kidney transplantation: Metabolic phenotyping and screening strategies.

Nefrologia·2026

Search research articles

Related Experiment Video

Updated: Dec 28, 2025

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

Inflammatory Targets in Diabetic Nephropathy.

Javier Donate-Correa^1,2, Desirée Luis-Rodríguez³, Ernesto Martín-Núñez^1,2,4

¹Unidad de Investigación, Hospital Universitario Nuestra Señora de Candelaria, 38010 Santa Cruz de Tenerife, Spain.

Journal of Clinical Medicine

|February 13, 2020

Summary

Diabetic nephropathy (DN) is a major complication of diabetes, leading to kidney and heart disease. Targeting inflammation offers a promising new strategy beyond traditional risk factor control to combat DN progression.

Keywords:

diabetes inflammation renal disease

More Related Videos

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

Characterization of a Novel Human Organotypic Retinal Culture Technique

Characterization of a Novel Human Organotypic Retinal Culture Technique

Published on: June 9, 2021

Related Experiment Videos

Last Updated: Dec 28, 2025

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

Characterization of a Novel Human Organotypic Retinal Culture Technique

Characterization of a Novel Human Organotypic Retinal Culture Technique

Published on: June 9, 2021

Area of Science:

Nephrology
Immunology
Endocrinology

Background:

Diabetic nephropathy (DN) is a leading cause of end-stage renal disease and cardiovascular complications in diabetes mellitus patients.
Traditional risk factors like hyperglycemia and hypertension do not fully explain DN progression.
Inflammation is increasingly recognized as a key driver of kidney damage in diabetic populations.

Purpose of the Study:

To review the role of proinflammatory molecules and mechanisms in DN pathogenesis.
To explore novel therapeutic strategies targeting inflammation for DN treatment.
To understand the immune response cascade in DN development.

Main Methods:

Literature review focusing on inflammation in diabetic nephropathy.
Analysis of proinflammatory pathways and signaling cascades.
Discussion of anti-inflammatory therapeutic targets.

Main Results:

Inflammation plays a critical role in the development and progression of DN.
Understanding inflammatory mechanisms is key to identifying new therapeutic targets.
Targeting inflammation presents a promising avenue for novel DN treatments.

Conclusions:

New therapeutic strategies for DN must consider inflammation beyond traditional risk factors.
Identifying and targeting specific inflammatory pathways can mitigate DN progression.
Further research into anti-inflammatory agents holds significant potential for managing diabetic kidney disease.